However a microRNA screen in HCT116 colon cancer cells shows that miR-125b has no effects on MCL1 expression or on cell viability and apoptosis when treated with the BCL2 inhibitor ABT-263 [136]. This evidence concerns the gene MCL1 and malignant colon neoplasm.